• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adjuvant chemotherapy with cyclophosphamide methotrexate and 5-fluorouracil (CMF) in stage II breast cancer in Indian patients.

作者信息

Shetty P A, Sarda P K, Majumdar A T, Pai V R, Shinde S R, D'Souza L J, Pinto J M, Jussawalla D J

出版信息

Indian J Cancer. 1985 Sep;22(3):239-44.

PMID:3843327
Abstract
摘要

相似文献

1
Adjuvant chemotherapy with cyclophosphamide methotrexate and 5-fluorouracil (CMF) in stage II breast cancer in Indian patients.环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）辅助化疗用于印度II期乳腺癌患者。
Indian J Cancer. 1985 Sep;22(3):239-44.
2
[The adjuvant chemotherapy of breast cancer].
Vopr Onkol. 1992;38(10):1187-94.
3
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.口服尿嘧啶和替加氟与经典的环磷酰胺、甲氨蝶呤、氟尿嘧啶相比，用于淋巴结阴性、高危乳腺癌患者术后化疗：国家乳腺癌辅助治疗研究01试验
J Clin Oncol. 2009 Mar 20;27(9):1368-74. doi: 10.1200/JCO.2008.18.3939. Epub 2009 Feb 9.
4
[5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers].
LARC Med. 1984 Nov;4(9):532-40.
5
Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.比较环磷酰胺、表柔比星和氟尿嘧啶与环磷酰胺、甲氨蝶呤和氟尿嘧啶用于绝经前淋巴结阳性乳腺癌女性的随机试验：加拿大国家癌症研究所临床试验组MA5试验的更新
J Clin Oncol. 2005 Aug 1;23(22):5166-70. doi: 10.1200/JCO.2005.09.423.
6
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.采用环磷酰胺、甲氨蝶呤和氟尿嘧啶辅助化疗治疗的20多年来淋巴结阳性原发性乳腺癌的自然病史：癌症与白血病B组的一项研究
J Clin Oncol. 2003 May 1;21(9):1825-35. doi: 10.1200/JCO.2003.09.006.
7
Chemotherapy with mitomycin-C, epidoxorubicin and vinblastine in CMF failing breast cancer patients.丝裂霉素-C、表柔比星和长春碱用于CMF方案治疗失败的乳腺癌患者的化疗。
Anticancer Res. 1990 Nov-Dec;10(6):1743-5.
8
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.HER-2扩增和拓扑异构酶IIα基因畸变作为预测标志物，用于接受蒽环类药物为基础的治疗或环磷酰胺、甲氨蝶呤和5-氟尿嘧啶随机治疗的淋巴结阳性乳腺癌患者。
Clin Cancer Res. 2002 May;8(5):1107-16.
9
Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).环磷酰胺、甲氨蝶呤和氟尿嘧啶（CMF）与醋酸亮丙瑞林激素去势作为淋巴结阳性绝经前乳腺癌患者辅助治疗的比较：TABLE研究（武田醋酸亮丙瑞林辅助乳腺癌研究）的初步结果
Anticancer Res. 2002 Jul-Aug;22(4):2325-32.
10
[Quality outcome of adjuvant CMF therapy in patients with breast cancer].[乳腺癌患者辅助性CMF治疗的质量结果]
Strahlenther Onkol. 2000 Jun;176(6):290-1.